| 1 |
Surov A, Strobel A, Borggrefe J, Wienke A. Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis. Eur Radiol 2023. [PMID: 36929392 DOI: 10.1007/s00330-023-09524-0] [Reference Citation Analysis]
|
| 2 |
Erickson N, Sullivan ES, Kalliostra M, Laviano A, Wesseling J. Nutrition care is an integral part of patient-centred medical care: a European consensus. Med Oncol 2023;40:112. [PMID: 36881207 DOI: 10.1007/s12032-023-01955-5] [Reference Citation Analysis]
|
| 3 |
Couderc AL, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Montégut C, Mebarki S, Geiss R, Ap Thomas Z, Noret A, Pierro M, Baldini C, Paillaud E, Pamoukdjian F. Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment. Nutrients 2023;15. [PMID: 36904192 DOI: 10.3390/nu15051193] [Reference Citation Analysis]
|
| 4 |
Luo L, Shen X, Fang S, Wan T, Liu P, Li P, Tan H, Fu Y, Guo W, Tang X. Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis. BMC Cancer 2023;23:127. [PMID: 36750774 DOI: 10.1186/s12885-023-10582-2] [Reference Citation Analysis]
|
| 5 |
Zhou M, Shen X, Fang S, Wan T, Liu P, Li P, Tan H, Fu Y, Guo W. Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis.. [DOI: 10.21203/rs.3.rs-2319788/v1] [Reference Citation Analysis]
|
| 6 |
Cheng E, Kirley J, Cespedes Feliciano EM, Caan BJ. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control 2022. [PMID: 35971021 DOI: 10.1007/s10552-022-01613-7] [Reference Citation Analysis]
|
| 7 |
Wu X, Wan T, Gao X, Fu M, Duan Y, Shen X, Guo W. Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment. Front Neurosci 2022;16:922331. [DOI: 10.3389/fnins.2022.922331] [Reference Citation Analysis]
|
| 8 |
Wan Q, Wang Z, Zhao R, Tu T, Shen X, Shen Y, Li T, Chen Y, Song Y. CT-determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia. Cancer Med 2023;12:1492-500. [PMID: 35848533 DOI: 10.1002/cam4.5040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Petrillo A. Multimodality Treatment in Metastatic Gastric Cancer: Working Together to Tailor the Continuum of Care. J Clin Med 2021;10:5492. [PMID: 34884194 DOI: 10.3390/jcm10235492] [Reference Citation Analysis]
|
